Literature DB >> 21686349

Acute prostatitis as an uncommon presentation of brucellosis.

Elif Hakko1, Melda Ozdamar, Salih Turkoglu, Semra Calangu.   

Abstract

The present report concerns a 46-year-old man who presented with acute prostatitis due to Brucella melitensis infection. He was first treated with doxycycline and ciprofloxacin, but after 3 months he was admitted again with the same diagnosis. The relapse was probably related to ciprofloxacin use, or the length of treatment not being sufficient. The patient was successfully treated with a combination of doxycycline and rifampin for 3 months. In conclusion, prostatitis due to Brucella, such as spondylitis, meningoencephalitis and endocarditis, should be treated for longer courses.

Entities:  

Year:  2009        PMID： 21686349      PMCID： PMC3027586          DOI： 10.1136/bcr.12.2008.1370

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  12 in total

1.  [Acute prostatitis as the 1st symptom of brucellosis].

Authors:  José Luis Rosales Leal; Miguel Tallada Buñuel; Eduardo Espejo Maldonado; José Manuel Cózar Olmo; Francisco Javier Vicente Prados; Antonio Martínez Morcillo; Soledad Buitrago Sivianes; Francisco Rodríguez Herrera; Manuel Ortiz Gorráiz
Journal:  Arch Esp Urol       Date:  2003-06       Impact factor: 0.436

Review 2.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  The sensitivity and specificity of Brucella agglutination tests.

Authors:  Ali Mert; Resat Ozaras; Fehmi Tabak; Muammer Bilir; Mesut Yilmaz; Celali Kurt; Seniz Ongoren; Melike Tanriverdi; Recep Ozturk
Journal:  Diagn Microbiol Infect Dis       Date:  2003-08       Impact factor: 2.803

Review 4.  Prostatitis and urinary tract infection in men: what's new; what's true?

Authors:  B A Lipsky
Journal:  Am J Med       Date:  1999-03       Impact factor: 4.965

5.  Multivariate model for predicting relapse in human brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa; M L Castillejos; P Geijo; M Rodríguez-Zapata
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

6.  Prostatitis and hepatitis due to Brucella melitensis: a case report.

Authors:  B Aygen; B Sümerkan; M Doğanay; E Sehmen
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

7.  Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis.

Authors:  C Agalar; S Usubutun; R Turkyilmaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-08       Impact factor: 3.267

8.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Authors:  J Solera; M Rodríguez-Zapata; P Geijo; J Largo; J Paulino; L Sáez; E Martínez-Alfaro; L Sánchez; M A Sepulveda; M D Ruiz-Ribó
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 9.  Human brucellosis.

Authors:  María Pía Franco; Maximilian Mulder; Robert H Gilman; Henk L Smits
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

10.  Characteristics of and risk factors for relapse of brucellosis in humans.

Authors:  J Ariza; J Corredoira; R Pallares; P F Viladrich; G Rufi; M Pujol; F Gudiol
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.